Eli Lilly Weight Loss Drug

Eli Lilly, Novo Nordisk and drug Wegovy

Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says

(Reuters) -Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, Brazil and Mexico by 2026, Chief Financial Officer Lucas Montarce said on Monday.

Investopedia on MSN · 2d

Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly

Key Takeaways Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly.The Swiss pharmaceutical firm signed an exclusive agreement with Zealand Pharma to produce treatments using Zealand's experimental petrelintide injectable.

USA TODAY on MSN · 8d

Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight-loss drug Wegovy.

Weight Loss, Food and Drug Administration

The New York Times · 3h

How Much Should Weight Loss Drugs Cost?

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.

ABC News · 1d

Compound versions of some weight loss drugs to be restricted

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.

USA TODAY on MSN · 10d

These discounted versions of popular weight-loss drugs are going away: What to know

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.

STAT2d

Eli Lilly’s Dave Ricks takes home $114 million as obesity drugs fuel company’s fortunes

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

7don MSN

US judge denies injunction, restricting copies of Lilly weight-loss drug

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

BioSpace4h

Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

3don MSN

Is Eli Lilly Stock a Buy?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Yahoo Finance4d

Eli Lilly plans to launch weight-loss drug in emerging markets this year

(Reuters) - Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of 2025 as production capacity ...

Data on new Novo Nordisk obesity drug disappoints in trial, shares drop

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Eli Lilly, Novo Nordisk and drug Wegovy

Weight Loss, Food and Drug Administration

Related topics